Annelies Wilder-Smith1. 1. Department of Disease Control, London School of Hygiene and Tropical Medicine, Bloomsbury, UK. annelies.wilder-smith@lshtm.ac.uk.
Abstract
PURPOSE OF REVIEW: Dengue is found in tropics and subtropics that are considered to be popular travel destinations. We set out to review the burden of dengue on international travelers. RECENT FINDINGS: GeoSentinel, a global network of travel medicine providers, has seen an increasing trend of dengue in returning travelers over the past decades. In Southeast Asia, annual proportionate morbidity increased from 50 dengue cases per 1000 ill-returned travelers in non-epidemic years to an average of 159 cases per 1000 travelers during epidemic years. Dengue is the leading cause of fever in returning travelers, having overtaken malaria for travelers to Southeast Asia. Most dengue seroconversion studies in travelers report an attack rate of around 5% depending on duration of travel and destination. Dengue vaccination would be justified for travelers. The first licensed dengue vaccine CYD-TDV is only recommended in seropositive individuals. This review considers preventive measures including how best to use the first licensed dengue vaccine CYD-TDV.
PURPOSE OF REVIEW: Dengue is found in tropics and subtropics that are considered to be popular travel destinations. We set out to review the burden of dengue on international travelers. RECENT FINDINGS: GeoSentinel, a global network of travel medicine providers, has seen an increasing trend of dengue in returning travelers over the past decades. In Southeast Asia, annual proportionate morbidity increased from 50 dengue cases per 1000 ill-returned travelers in non-epidemic years to an average of 159 cases per 1000 travelers during epidemic years. Dengue is the leading cause of fever in returning travelers, having overtaken malaria for travelers to Southeast Asia. Most dengue seroconversion studies in travelers report an attack rate of around 5% depending on duration of travel and destination. Dengue vaccination would be justified for travelers. The first licensed dengue vaccine CYD-TDV is only recommended in seropositive individuals. This review considers preventive measures including how best to use the first licensed dengue vaccine CYD-TDV.
Entities:
Keywords:
Dengue; Dengue vaccine; GeoSentinel; Personal protection; Seroconversion; Travelers
Authors: Asma Sohail; Sarah L McGuinness; Rachel Lightowler; Karin Leder; Bismi Jomon; Christopher A Bain; Anton Y Peleg Journal: Intern Med J Date: 2019-01 Impact factor: 2.048
Authors: Sri Rezeki Hadinegoro; Jose Luis Arredondo-García; Maria Rosario Capeding; Carmen Deseda; Tawee Chotpitayasunondh; Reynaldo Dietze; H I Hj Muhammad Ismail; Humberto Reynales; Kriengsak Limkittikul; Doris Maribel Rivera-Medina; Huu Ngoc Tran; Alain Bouckenooghe; Danaya Chansinghakul; Margarita Cortés; Karen Fanouillere; Remi Forrat; Carina Frago; Sophia Gailhardou; Nicholas Jackson; Fernando Noriega; Eric Plennevaux; T Anh Wartel; Betzana Zambrano; Melanie Saville Journal: N Engl J Med Date: 2015-07-27 Impact factor: 91.245
Authors: Henrik Salje; Derek A T Cummings; Isabel Rodriguez-Barraquer; Leah C Katzelnick; Justin Lessler; Chonticha Klungthong; Butsaya Thaisomboonsuk; Ananda Nisalak; Alden Weg; Damon Ellison; Louis Macareo; In-Kyu Yoon; Richard Jarman; Stephen Thomas; Alan L Rothman; Timothy Endy; Simon Cauchemez Journal: Nature Date: 2018-05-23 Impact factor: 49.962
Authors: Simon Pollett; Caitlin H Kuklis; David A Barvir; Richard G Jarman; Rachel M Romaine; Brett M Forshey; Gregory D Gromowski Journal: PLoS Negl Trop Dis Date: 2022-01-21